DJ Biogen Inc. Stock Underperforms Friday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Biogen Inc. $(BIIB)$ slipped 1.40% to $138.37 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 1.97% to 5,580.94 and Dow Jones Industrial Average falling 1.69% to 41,583.90.
This was the stock's second consecutive day of losses.
Biogen Inc. closed 41.86% short of its 52-week high of $238.00, which the company reached on July 12th.
The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson $(JNJ)$ rose 0.36% to $163.71, Pfizer Inc. $(PFE)$ rose 0.80% to $25.21, and AbbVie Inc. $(ABBV)$ rose 1.27% to $205.29.
Trading volume (1.1 M) remained 537,924 below its 50-day average volume of 1.6 M.
Data source: Dow Jones Market Data, FactSet. Data compiled March 28, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
March 28, 2025 17:06 ET (21:06 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.